Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Advice on scheduling of cannabis-derived medicinal products

    • Published
    • Correspondence
    • ACMD
  2. ACMD members' register of interests

    • Updated
    • Corporate report
    • ACMD
  3. Medicinal cannabis review part 2 commissioned

    • Published
    • News story
    • Home Office and ACMD
  4. Commission to the ACMD: scheduling under the Misuse of Drugs Regulations 2001

    • Published
    • Guidance
    • Home Office and ACMD
  5. Drug-related harms in homeless populations: public evidence gathering day

    • Published
    • News story
    • ACMD
  6. Legitimate use of controlled drugs: research and healthcare

    • Updated
    • Correspondence
    • ACMD
  7. Custody-community transitions: public evidence gathering day

    • Published
    • News story
    • ACMD
  8. Letter requesting evidence: custody-community transitions

    • Published
    • Correspondence
    • ACMD
  9. Advice on amending the Misuse of Drugs (Safe Custody) Regulations 1973

    • Published
    • Correspondence
    • ACMD
  10. Prescribing of controlled drugs by therapeutic radiographers: further advice

    • Updated
    • Correspondence
    • ACMD
  11. Further new member appointed to the ACMD

    • Published
    • News story
    • ACMD
  12. ACMD work programme for 2017 to 2019

    • Published
    • Correspondence
    • ACMD
  13. Eight new members appointed to the ACMD

    • Published
    • News story
    • ACMD
  14. ACMD letter to the Home Secretary: invitation to the drug strategy board

    • Published
    • Correspondence
    • ACMD
  15. ACMD warns ministers of falling local funding for drug treatment services

    • Published
    • News story
    • ACMD
  16. Commissioning impact on drug treatment

    • Published
    • Corporate report
    • ACMD
  17. Image and Performance Enhancing Drugs: public evidence gathering day

    • Published
    • News story
    • ACMD
  18. Home Office Science non-departmental public bodies (NDPBs): triennial review

    • Published
    • Corporate report
    • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group
  19. Psychoactive Substances Bill: evaluation review

    • Published
    • Corporate report
    • ACMD
  20. Drug strategy 2016: development review

    • Published
    • Corporate report
    • ACMD
  21. Methiopropamine: a review of the evidence of use and harm

    • Published
    • Corporate report
    • ACMD
  22. Now recruiting: Advisory Council on the Misuse of Drugs members

    • Published
    • News story
    • ACMD
  23. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • Updated
    • Policy paper
    • ACMD
  24. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • Updated
    • Correspondence
    • Home Office and ACMD
  25. Advice on U-47,700, etizolam and other designer benzodiazepines

    • Updated
    • Correspondence
    • ACMD
  26. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • Published
    • Correspondence
    • ACMD
  27. Misuse of Drugs Regulations 2001: impact on research

    • Published
    • Correspondence
    • ACMD
  28. Plant cannabinoids: ACMD report

    • Published
    • Policy paper
    • ACMD
  29. Medicines supplementing use of other illicit drugs, says ACMD

    • Published
    • Press release
    • ACMD
  30. Diversion & illicit supply of medicines

    • Published
    • Policy paper
    • ACMD
  31. New chair of Advisory Council on the Misuse of Drugs

    • Published
    • Press release
    • Home Office and ACMD
  32. ACMD tells ministers drug-related deaths will continue to rise if treatment programmes are not maintained

    • Published
    • Press release
    • ACMD
  33. Reducing opioid-related deaths in the UK

    • Published
    • Independent report
    • ACMD
  34. 'Third generation' synthetic cannabinoids

    • Updated
    • Correspondence
    • ACMD
  35. Temporary class drug order on methiopropamine

    • Published
    • Correspondence
    • ACMD
  36. Problems for Ageing Drug Users Working Group: public meeting invitation

    • Published
    • Promotional material
    • ACMD
  37. Independent prescribing of controlled drugs by therapeutic radiographers

    • Published
    • Correspondence
    • ACMD
  38. Advisory Council on the Misuse of Drugs recruiting new chair

    • Published
    • News story
    • ACMD
  39. ACMD work programme for 2016

    • Published
    • Correspondence
    • ACMD
  40. ACMD review of alkyl nitrites (poppers)

    • Published
    • Correspondence
    • ACMD